Peter Mesenbrink

Peter Mesenbrink, Executive Director, Biostatistics, Novartis

Articles

Establishing a Basis for Secondary Use Standards for Clinical Trials

March 08, 2023

Study seeks to understand how different forms of data meet the needs of researchers.